MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Total Assets 2011-2026 | BRKR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.81 B | 4.25 B | 3.61 B | 3.65 B | 3.05 B | 2.77 B | 2.13 B | 1.95 B | 1.81 B | 1.73 B | 1.86 B | 1.99 B | 1.86 B | 1.71 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.81 B | 1.71 B | 2.73 B |
Quarterly Total Assets Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.43 B | 5.93 B | 5.81 B | 6.11 B | 5.9 B | - | 4.25 B | 3.82 B | 3.86 B | 3.76 B | 3.61 B | 3.34 B | - | 3.55 B | 3.65 B | 3.13 B | 3.09 B | 3.03 B | 3.05 B | 3.05 B | 3.05 B | 3.05 B | 2.77 B | 2.77 B | 2.77 B | 2.77 B | 2.13 B | 2.13 B | 2.13 B | 2.13 B | 1.95 B | 1.95 B | 1.95 B | 1.95 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.99 B | 1.99 B | 1.99 B | 1.99 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.71 B | 1.71 B | 1.71 B | 1.71 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.43 B | 1.71 B | 2.73 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
124 M | $ 9.11 | -10.77 % | $ 260 M |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 13.94 | -0.71 % | $ 2.09 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 7.0 | 5.74 % | $ 503 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.38 | -4.58 % | $ 163 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.49 | 2.05 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 31.87 | 2.07 % | $ 1.47 B | USA |
 |
Aziyo Biologics
AZYO
|
43.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 275.33 | 2.19 % | $ 7.77 B | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 75.65 | 2.97 % | $ 112 B | USA |
 |
InMode Ltd.
INMD
|
766 M | $ 14.0 | 0.29 % | $ 905 M | Israel |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 14.09 | -7.06 % | $ 381 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 45.89 | -0.18 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.48 | 1.02 % | $ 146 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.18 | 1.09 % | $ 204 M | USA |
 |
Establishment Labs Holdings
ESTA
|
347 M | $ 77.41 | -1.12 % | $ 2.18 B |  Costa-rica |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.53 | -0.3 % | $ 121 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 96.27 | 0.06 % | $ 13 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 26.14 | 0.5 % | $ 1.78 B | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.11 | -2.76 % | $ 1.28 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 11.13 | -4.01 % | $ 857 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.73 | 2.57 % | $ 39.7 M | USA |
 |
Inogen
INGN
|
296 M | $ 6.4 | 6.53 % | $ 151 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
98.3 M | $ 102.4 | 1.89 % | $ 1.3 B | USA |